Human BCL2A1 ELISA Kit (V2LY-0626-LY5506)

Chilakamarti, R. (2021). Lung Epithelial Regulation of BCL2 Related Protein A1 (BCL2A1) by Coronaviruses (SARS-CoV) and Type I Interferon Signaling. bioRxiv.

Liu, F., Pan, R., Ding, H., Gu, L., Yang, Y., Li, C., ... & Nie, Y. (2021). UBQLN4 is an ATM substrate that stabilizes the anti‐apoptotic proteins BCL2A1 and BCL2L10 in mesothelioma. Molecular Oncology.

Li, X., Dou, J., You, Q., & Jiang, Z. (2021). Inhibitors of BCL2A1/Bfl-1 Protein: Potential Stock in Cancer Therapy. European Journal of Medicinal Chemistry, 113539.

Zheng, Q., Gan, G., Gao, X., Luo, Q., & Chen, F. (2021). Targeting the IDO-BCL2A1-Cytochrome c Pathway Promotes Apoptosis in Oral Squamous Cell Carcinoma. OncoTargets and therapy, 14, 1673.

Lin, P., Li, J., Ye, F., Fu, W., Hu, X., Shao, Z., & Song, C. (2020). KCNN4 induces multiple chemoresistance in breast cancer by regulating BCL2A1. American journal of cancer research, 10(10), 3302.

Kim, J. T., Cho, H. J., Cho, M. Y., Lim, J., Park, E. S., Lim, J. S., & Lee, H. G. (2019). Prenylated Rab acceptor RABAC1 inhibits anti-apoptotic protein BCL2A1 and induces apoptosis. Biochemical and biophysical research communications, 513(4), 940-946.

Hiraki, M., Maeda, T., Mehrotra, N., Jin, C., Alam, M., Bouillez, A., ... & Kufe, D. (2018). Targeting MUC1-C suppresses BCL2A1 in triple-negative breast cancer. Signal transduction and targeted therapy, 3(1), 1-8.

Sochalska, M., Schuler, F., Weiss, J. G., Prchal-Murphy, M., Sexl, V., & Villunger, A. (2017). MYC selects against reduced BCL2A1/A1 protein expression during B cell lymphomagenesis. Oncogene, 36(15), 2066-2073.

Berberich, I., & Hildeman, D. A. (2017). The Bcl2a1 gene cluster finally knocked out: first clues to understanding the enigmatic role of the Bcl-2 protein A1. Cell death and differentiation, 24(4), 572.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols